Open | $1.630 |
Close | $1.530 |
Volume / Avg. | 741.711K / 728.186K |
Day Range | 1.530 - 1.639 |
52 Wk Range | 1.050 - 5.850 |
Market Cap | $66.183M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 7.04% |
Days to Cover | 5.96 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Eyenovia (NASDAQ: EYEN) through any online brokerage.
Other companies in Eyenovia’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and VYNE Therapeutics (NASDAQ:VYNE).
The latest price target for Eyenovia (NASDAQ: EYEN) was reported by HC Wainwright & Co. on Wednesday, March 6, 2024. The analyst firm set a price target for 12.00 expecting EYEN to rise to within 12 months (a possible 700.00% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Eyenovia (NASDAQ: EYEN) is $1.5 last updated March 18, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Eyenovia.
Eyenovia’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Eyenovia.
Eyenovia is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.